Literature DB >> 6111617

Long-term clinical effect of calcium inhibitors in hypertrophic cardiomyopathy compared to the effect of beta-blocking agents. A preliminary report with special reference to the beneficial effect of nifedipine on angina pectoris.

T Koide, M Kakihana, Y Takabatake, M Iizuka, Y Uchida, K Ozeki, S Morooka, A Kato, S Tanaka, T Oya, S Momomura, S Murao.   

Abstract

Long-term clinical effects of beta-blockers (propranolol in most cases) and calcium inhibitors (nifedipine in most cases) were studied in 16 patients with hypertrophic cardiomyopathy. On overall subjective symptoms, beta-blockers were effective in 50% of symptomatic patients, while calcium inhibitors were effective in only 33%. On angina pectoris, however, calcium inhibitors were superior to beta-blockers in our patients. Blood pressure decreased with each drug, and the decrease was significant with nifedipine. Otherwise there was no change in physical findings with either drug. Long-term (more than 6 months) use of beta-blockers resulted in an increase in cardiothoracic ratio on chest X-ray, a decrease in left ventricular ejection fraction on echocardiogram and more pronounced ST-T change on electrocardiogram. Prolonged use of nifedipine resulted in a slight decrease in cardiothoracic ratio, but no systematic change on echocardiogram and on electrocardiogram.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6111617     DOI: 10.1536/ihj.22.87

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Short- and long-term effects of nisoldipine on cardiac function and exercise tolerance in patients with hypertrophic cardiomyopathy.

Authors:  T Tokushima; T Utsunomiya; T Ogawa; K Kidoh; Y Ohtsubo; T Ryu; K Yoshida; T Ogata; S Tsuji; S Matsuo
Journal:  Basic Res Cardiol       Date:  1996 Jul-Aug       Impact factor: 17.165

Review 3.  Calcium antagonists--future uses.

Authors:  R Krebs
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.